Sio Gene Therapies Inc

NASDAQ:SIOX  
0.36
0.00 (-0.06%)
Earnings Announcements

Sio Gene Therapies Announces Fiscal Year 2021 Year-End Financial Results

Published: 06/14/2022 11:31 GMT
Sio Gene Therapies Inc (SIOX) - Sio Gene Therapies Announces Fiscal Year 2021 Year-end Financial Results.
Q4 Loss per Share $0.18.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.16

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.17

More details on our Analysts Page.